Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 30 citing articles:

Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Manisha H. Shah, Whitney Goldner, Al B. Benson, et al.
Journal of the National Comprehensive Cancer Network (2021) Vol. 19, Iss. 7, pp. 839-868
Open Access | Times Cited: 428
What Is New in the 2017 World Health Organization Classification and 8th American Joint Committee on Cancer Staging System for Pancreatic Neuroendocrine Neoplasms?
Jooae Choe, Kyung Won Kim, Hyoung Jung Kim, et al.
Korean Journal of Radiology (2018) Vol. 20, Iss. 1, pp. 5-5
Open Access | Times Cited: 89
Imaging of Pancreatic Neuroendocrine Neoplasms
Giuditta Chiti, Giulia Grazzini, Diletta Cozzi, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 17, pp. 8895-8895
Open Access | Times Cited: 31
The Role of Surgery for Pancreatic Neuroendocrine Tumors
Ioannis A. Ziogas, Robin Schmitz, Demetrios Moris, et al.
Anticancer Research (2022) Vol. 42, Iss. 2, pp. 629-639
Open Access | Times Cited: 15
Development and Validation of a Nomogram for Predicting Overall Survival in Pancreatic NeuroendocrineTumors
Dong-liu Miao, Wei Song, Jun Qian, et al.
Translational Oncology (2018) Vol. 11, Iss. 5, pp. 1097-1103
Open Access | Times Cited: 25
Association between MGMT status and response to alkylating agents in patients with neuroendocrine neoplasms: a systematic review and meta-analysis
Zhirong Qi, Huangying Tan
Bioscience Reports (2020) Vol. 40, Iss. 3
Open Access | Times Cited: 19
Prognostic Validity of the American Joint Committee on Cancer Eighth Edition TNM Staging System for Surgically Treated and Well-Differentiated Pancreatic Neuroendocrine Tumors
Min Yang, Yi Zhang, Lin Zeng, et al.
Pancreas (2019) Vol. 48, Iss. 5, pp. 613-621
Closed Access | Times Cited: 18
c‐Myc promotes lymphatic metastasis of pancreatic neuroendocrine tumor through VEGFC upregulation
Tsung‐Ming Chang, Pei‐Yi Chu, Wen‐Chun Hung, et al.
Cancer Science (2020) Vol. 112, Iss. 1, pp. 243-253
Open Access | Times Cited: 17
Prognostic value of CT-based radiomics in grade 1–2 pancreatic neuroendocrine tumors
Subin Heo, Hyo Jung Park, Hyoung Jung Kim, et al.
Cancer Imaging (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Development and Validation of a Modified Eighth AJCC Staging System for Primary Pancreatic Neuroendocrine Tumors
Xu‐Feng Zhang, Feng Xue, Zheng Wu, et al.
Annals of Surgery (2020) Vol. 275, Iss. 6, pp. e773-e780
Open Access | Times Cited: 16
Surgical Management and Long-Term Evaluation of Pancreatic Neuroendocrine Tumors
Shadin Ghabra, Bhavishya Ramamoorthy, Stephen G. Andrews, et al.
Surgical Clinics of North America (2024) Vol. 104, Iss. 4, pp. 891-908
Closed Access | Times Cited: 1
Neuroendocrine neoplasms of the digestive system- current classification and terminology
Agata Bałdys‐Waligórska, Andrzej Nowak
Nowotwory Journal of Oncology (2021) Vol. 71, Iss. 1, pp. 26-37
Open Access | Times Cited: 8
A Machine Learning Decision Support System (DSS) for Neuroendocrine Tumor Patients Treated with Somatostatin Analog (SSA) Therapy
Jasminka Hasić Telalović, Serena Pillozzi, Rachele Fabbri, et al.
Diagnostics (2021) Vol. 11, Iss. 5, pp. 804-804
Open Access | Times Cited: 8
State of the Art and Recent Developments of Radiopharmaceuticals for Pancreatic Neuroendocrine Tumors Imaging
Angela Carollo, Stefano Papi, Chiara Maria Grana, et al.
Current Radiopharmaceuticals (2019) Vol. 12, Iss. 2, pp. 107-125
Closed Access | Times Cited: 8
Competing risks and cause-specific mortality in patients with pancreatic neuroendocrine tumors
Zhuyin Li, Shuai Du, Wei Feng, et al.
European Journal of Gastroenterology & Hepatology (2019) Vol. 31, Iss. 7, pp. 749-755
Closed Access | Times Cited: 7
Patterns and predictors of pancreatic neuroendocrine tumor prognosis: Are no two leaves alike?
Heli Gao, WenQuan Wang, Xianjun Yu, et al.
Critical Reviews in Oncology/Hematology (2021) Vol. 167, pp. 103493-103493
Closed Access | Times Cited: 6
What Are the Place and Modalities of Surgical Management for Pancreatic Neuroendocrine Neoplasms? A Narrative Review
Samuel Frey, Éric Mirallié, M. Le Bras, et al.
Cancers (2021) Vol. 13, Iss. 23, pp. 5954-5954
Open Access | Times Cited: 4
Risk Stratification of Pancreatic Neuroendocrine Neoplasms Based on Clinical, Pathological, and Molecular Characteristics
Jin Ho Choi, Woo Hyun Paik
Journal of Clinical Medicine (2022) Vol. 11, Iss. 24, pp. 7456-7456
Open Access | Times Cited: 3
A comprehensive validation of the novel 8th edition of American Joint Committee on Cancer staging manual for the long-term survivals of patients with non-functional pancreatic neuroendocrine neoplasms
Min Yang, Lin Zeng, Wenqing Yao, et al.
Medicine (2020) Vol. 99, Iss. 46, pp. e22291-e22291
Open Access | Times Cited: 3
Exploring the therapeutic potential of simvastatin in pancreatic neuroendocrine neoplasms: insights into cell cycle regulation and apoptosis
Xiaoting Shi, Lijun Yan, Feiyu Lu, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 8, pp. 4315-4323
Open Access
Prognostic Nomograms to Predict Overall Survival and Cancer-Specific Survival of Patients With Pancreatic Neuroendocrine Tumors
Zuoli Song, Sumei Wang, Yujing Wu, et al.
Pancreas (2021) Vol. 50, Iss. 3, pp. 414-422
Closed Access | Times Cited: 3
Prognostic validity of the American joint committee on cancer eighth edition staging system for well-differentiated pancreatic neuroendocrine tumors
Hebin Wang, Ding Ding, Tingting Qin, et al.
HPB (2021) Vol. 24, Iss. 5, pp. 681-690
Open Access | Times Cited: 3
Pancreatic neuroendocrine neoplasms: a 2022 update for radiologists
Samuel J. Galgano, Ajaykumar C. Morani, Dheeraj Reddy Gopireddy, et al.
Abdominal Radiology (2022) Vol. 47, Iss. 12, pp. 3962-3970
Closed Access | Times Cited: 2
The eighth version of American Joint Committee on Cancer nodal classification for high grade pancreatic neuroendocrine tumor should be generalized for the whole population with this disease
Muxing Li, Hangyan Wang, Chunhui Yuan, et al.
Medicine (2020) Vol. 99, Iss. 37, pp. e22089-e22089
Open Access | Times Cited: 2
Bleeding and malignant pancreatic neuroendocrine neoplasms: A Malaysian case series
Muthu Viknesh, Faqihuddin Bin Hisham, Padmaan Sankaran, et al.
International Journal of Hepatobiliary and Pancreatic Diseases (2019) Vol. 9, Iss. 2, pp. 1-6
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top